PPADS
![]() | |
| Names | |
|---|---|
| IUPAC name
4-[(E)-{4-formyl-5-hydroxy-6-methyl-3-[(phosphonooxy)methyl]pyridin-2-yl}diazenyl]benzene-1,3-disulfonic acid | |
| Other names
PPADS | |
| Identifiers | |
| 149017-66-3 192575-19-2 (tetrasodium salt) | |
| ChEBI | CHEBI:34941 |
| ChemSpider | 20136164 |
| Jmol interactive 3D | Image |
| PubChem | 6093163 6532796 (tetrasodium salt) |
| |
| |
| Properties | |
| C14H14N3O12PS2 | |
| Molar mass | 511.37 g·mol−1 |
| Appearance | Orange solid |
| 100 mM (tetrasodium salt)[1] | |
| Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa). | |
| Infobox references | |
PPADS (pyridoxalphosphate-6-azophenyl-2',4'-disulfonic acid) is a selective purinergic P2X antagonist.[2] It is able to block contractions of rabbit vas deferens induced by ATP or α,β,methylene-ATP. It appears to be relatively selective for P2X receptors, having no appreciable activity at α1 adrenergic, muscarinic M2 and M3, histamine H1, and adenosine A1 receptors.[3]
References
- ↑ PPADS tetrasodium salt, Santa Cruz Biotechnology
- ↑ Ziganshin, AU (December 1993). "PPADS selectively antagonizes P2X-purinoceptor-mediated responses in the rabbit urinary bladder.". British Journal of Pharmacology 110 (4): 1491–95. doi:10.1111/j.1476-5381.1993.tb13990.x. PMC 2175839. PMID 8306091. Retrieved 24 July 2011.
- ↑ Lambrecht, G. (1992). "PPADS, a novel functionally selective antagonist of P2 purinoreceptor mediated responses". European Journal of Pharmacology 217: 217–19. doi:10.1016/0014-2999(92)90877-7. PMID 1330591.
| ||||||||||||||||||||||||||||||||||||||||||||||||||
This article is issued from Wikipedia - version of the Thursday, March 10, 2016. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.
